Next Article in Journal
A Computational Study of Calcium(II) and Copper(II) Ion Binding to the Hyaluronate Molecule
Previous Article in Journal
Anti-Epidermal Growth Factor Receptor (EGFR) Antibodies Overcome Resistance of Ovarian Cancer Cells to Targeted Therapy and Natural Cytotoxicity
Int. J. Mol. Sci. 2012, 13(9), 12017-12035; doi:10.3390/ijms130912017
Review

Inhibition of GTRAP3-18 May Increase Neuroprotective Glutathione (GSH) Synthesis

 and
*
Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan
* Author to whom correspondence should be addressed.
Received: 9 July 2012 / Revised: 6 August 2012 / Accepted: 10 September 2012 / Published: 20 September 2012
(This article belongs to the Section Biochemistry, Molecular Biology and Biophysics)
View Full-Text   |   Download PDF [1049 KB, uploaded 19 June 2014]   |   Browse Figures
SciFeed

Abstract

Glutathione (GSH) is a tripeptide consisting of glutamate, cysteine, and glycine; it has a variety of functions in the central nervous system. Brain GSH depletion is considered a preclinical sign in age-related neurodegenerative diseases, and it promotes the subsequent processes toward neurotoxicity. A neuroprotective mechanism accomplished by increasing GSH synthesis could be a promising approach in the treatment of neurodegenerative diseases. In neurons, cysteine is the rate-limiting substrate for GSH synthesis. Excitatory amino acid carrier 1 (EAAC1) is a neuronal cysteine/glutamate transporter in the brain. EAAC1 translocation to the plasma membrane promotes cysteine uptake, leading to GSH synthesis, while being negatively regulated by glutamate transport associated protein 3-18 (GTRAP3-18). Our recent studies have suggested GTRAP3-18 as an inhibitory factor for neuronal GSH synthesis. Inhibiting GTRAP3-18 function is an endogenous mechanism to increase neuron-specific GSH synthesis in the brain. This review gives an overview of EAAC1-mediated GSH synthesis, and its regulatory mechanisms by GTRAP3-18 in the brain, and a potential approach against neurodegeneration.
Keywords: glutathione; cysteine uptake; GTRAP3-18; EAAC1; neurodegeneration glutathione; cysteine uptake; GTRAP3-18; EAAC1; neurodegeneration
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
RIS
MDPI and ACS Style

Aoyama, K.; Nakaki, T. Inhibition of GTRAP3-18 May Increase Neuroprotective Glutathione (GSH) Synthesis. Int. J. Mol. Sci. 2012, 13, 12017-12035.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert